コラーゲネーゼ機能化されたリポソームは,臓がんにおけるストロマ障害を克服する
Jee-Eun Hwang1,2,3, Miyeon Jeon4, Hyunjoon Yim4
1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.
ACS nano
|February 18, 2026
まとめ
コラーゲナゼ (GLCLs) と結合したゲムシタビンを含むリポソームは,臓がんにおける線維性障壁を分解する. これは薬の浸透を高め,腫瘍の成長を大幅に抑制し,新しい治療戦略を提供します.
科学分野:
- バイオメディカルエンジニアリング
- ナノテクノロジー ナノテクノロジー
- 腫瘍学 腫瘍学
背景:
- 管性腺癌 (PDAC) は,薬物の投与を阻害し,治療の有効性を制限する,濃厚でコラーゲンに富んだストロマによって特徴付けられます.
- PDACの繊維細胞外マトリックス (ECM) は物理的な障壁を作り,血管 perfusion を減少させ,ゲムシタビンなどの化学療法薬の浸透を抑制します.
研究 の 目的:
- ゲムシタビンを含むコラーゲナゼ結合リポソーム (GLCL) の開発と評価を目的として,PDACにおける薬剤投与の強化を図る.
- GLCLsがコラーゲン系ECMを酵素的に再構成し,腫瘍内薬剤の浸透性を改善する能力を調査する.
主な方法:
- GLCLの合成と特徴付け,酵素活性,安定性,および薬理学プロフィールを評価する.
- PDACを搭載したマウスモデルにおけるGLCLの評価は,in vivoイメージング,ex vivo光,定量的な分解電スプレーイオン化質量スペクトロメトリ画像 (DESI-MSI) を用いた.
- GLCLによる腫瘍成長抑制と非機能化されたリポソーム (GLL) とフリーゲムシタビンの比較.
主要な成果:
- GLCLは,GLLと比較して,保持されたコラーゲナース活性,延長された循環,および優れた腫瘍蓄積を示した.
- GLCLは,より深く,より均質なゲムシタビンの口内浸透を達成しました.
- GLCLは,同量の投与でGLL (10.9%) よりも6倍高い腫瘍成長抑制 (69.8%) を示した.
結論:
- GLCLは,酵素によるECMリモデリングを通じて,PDACにおける線維コラーゲンバリアを効果的に克服します.
- このナノキャリア媒介薬剤投与戦略は,深い腫瘍内薬剤の浸透を可能にし,PDAC治療の有望で臨床的に翻訳可能なアプローチを提供します.
- この研究は,マルチスケール画像アプローチを使用して,PDACにおけるナノキャリア媒介薬剤浸透の分子レベルでの検証を提供します.
関連する概念動画
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...